Please upgrade your browser.
NewLink Genetics Corporation, a biopharmaceutical company, has initiated a first in human Phase I clinical trial of HyperAcute Renal immunotherapy in patients with metastatic renal cell cancer.
Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma
Renal cell carcinoma (RCC) frequently metastasizes to the spine, and the prognosis can be quite variable.
Public online voting is live to determine 2014 winner
If the president wants to change the health-care law, he must ask Congress to do it.
40-year study validates the link between smoking and the development of cancer. Smoking is a risk factor for kidney cancer.
The net result of ObamaCare, thus far, is that more people have lost coverage under ObamaCare, than have gained coverage. And the worst is yet to come.
Science magazine chooses for its section 2013 Breakthrough of the Year, the subject of cancer immunotherapy, claiming that this form of treatment has marked a "turning point", as the human body's own immune system is honed in to direct the fight against the cancerous cells.
Rosetta Genomics Ltd., a molecular diagnostics company, has received conditional approval from the New York State Department of Health, or NYSDOH, for the Rosetta Kidney Cancer Test for testing on patient samples from the state.
Not only experts, but also novice users can find this tool useful in quickly finding answers to all their Cancer-related questions. Currently, the expert's knowledge base covers nearly 14,000 questions, and several million chunks of information.
110 pages and 13 languages, written by experts in the treatment of renal cancers.
|Powered by NeonCRM|